Turnover: 1 million EUR (2022)
Country: France
Genomic Vision is listed on the Euronext regulated market in Paris under the symbol GV.
It specializes in advances in precision genomics to accelerate the identification and bio-production of advanced cell and gene therapies.
In partnership with its customers and partners, the company provides high-quality genomic solutions to improve the quality and production standards of large-scale gene therapies.
Studies mentioning this company
The bioanalysis market - France
Other companies mentioned:
- Eurofins
- Carso groupe
- Mérieux NutriSciences
- SGS
- Intertek
- Bureau Veritas BV
- Phytocontrol
- Qualtech (IFBM Groupe)
- Valbiotis
- Abbott Groupe
- Agilent Technologies
- Beckman Coulter
- Bio-Rad Laboratories
- Genomic Vision
- LFB Groupe
- Novacyt
- Qiagen
- Randox Laboratories
- Roche Diagnostics France (Roche Group)
- Thermo Fisher Diagnostics